MENU
+Compare
NBIX
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$105.75
Change
+$2.53 (+2.45%)
Capitalization
13.72B

NBIX Neurocrine Biosciences Forecast, Technical & Fundamental Analysis

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States... Show more

Industry: #Biotechnology
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for NBIX with price predictions
Apr 23, 2025

NBIX's RSI Indicator ascends from oversold territory

The RSI Oscillator for NBIX moved out of oversold territory on April 14, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In of the 31 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 21, 2025. You may want to consider a long position or call options on NBIX as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NBIX just turned positive on April 16, 2025. Looking at past instances where NBIX's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NBIX advanced for three days, in of 298 cases, the price rose further within the following month. The odds of a continued upward trend are .

NBIX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NBIX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NBIX entered a downward trend on April 07, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.297) is normal, around the industry mean (61.171). P/E Ratio (57.202) is within average values for comparable stocks, (90.174). Projected Growth (PEG Ratio) (0.464) is also within normal values, averaging (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (7.564) is also within normal values, averaging (20.123).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NBIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NBIX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NBIX is expected to report earnings to fall 54.22% to 77 cents per share on May 05

Neurocrine Biosciences NBIX Stock Earnings Reports
Q1'25
Est.
$0.77
Q4'24
Beat
by $0.12
Q3'24
Beat
by $0.29
Q2'24
Beat
by $0.50
Q1'24
Beat
by $0.13
The last earnings report on February 06 showed earnings per share of $1.69, beating the estimate of $1.57. With 478.82K shares outstanding, the current market capitalization sits at 13.72B.
A.I. Advisor
published General Information

General Information

a product based biopharmaceutical company

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
12780 El Camino Real
Phone
+1 858 617-7600
Employees
1400
Web
https://www.neurocrine.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
CTXC.X0.0789870.005911
+8.09%
Cortex cryptocurrency
FUN.X0.0062510.000445
+7.66%
FUNToken cryptocurrency
CELO.X0.3283910.001930
+0.59%
Celo cryptocurrency
VEN.X0.016788N/A
N/A
ImpulseVen cryptocurrency
TIA.X2.764851-0.010921
-0.39%
Celestia cryptocurrency

NBIX and Stocks

Correlation & Price change

A.I.dvisor tells us that NBIX and LFCR have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NBIX and LFCR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBIX
1D Price
Change %
NBIX100%
+1.45%
LFCR - NBIX
32%
Poorly correlated
+2.43%
EOLS - NBIX
30%
Poorly correlated
+7.36%
ACET - NBIX
25%
Poorly correlated
+5.90%
HROW - NBIX
24%
Poorly correlated
+3.97%
ALKS - NBIX
23%
Poorly correlated
+0.15%
More